サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606422

着床前遺伝子診断市場：タイプ別、技術別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Preimplantation Genetic Diagnosis Market, By Type, By Technology, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
着床前遺伝子診断市場：タイプ別、技術別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

着床前遺伝子診断市場は2023年に5,780万米ドルと評価され、2024年から2032年にかけてCAGR 7.80%で拡大

着床前遺伝子診断市場-市場力学

遺伝性疾患の有病率の上昇が市場の成長を促進すると予測される

着床前遺伝子診断（PGD）は、特定の遺伝子異常のない胚の選択を可能にすることで、重要な解決策を提供します。健康な出産の促進に重点を置くことで、生殖戦略にPGDを取り入れるカップルが増えています。世界保健機関（WHO）によると、遺伝性疾患や先天異常は出生児の約2％～5％にみられ、小児科入院の30％近くを占め、先進国では小児死亡事故の約50％を引き起こしています。

また、不妊治療クリニックの拡大や遺伝子検査技術の進歩は、市場に成長機会をもたらす可能性があります。しかし、PGDサービスに関連する高コストが市場拡大の妨げになる可能性があります。

着床前遺伝子診断市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約7.80%のCAGRで毎年成長すると推定されます。

タイプセグメンテーションに基づくと、異数性は2023年に最大の市場シェアを示すと予測されました。

技術セグメンテーションでは、ポリメラーゼ連鎖反応（PCR）が2023年の主要タイプでした。

エンドユーザーセグメンテーションに基づくと、2023年には病院が主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

着床前遺伝子診断市場-セグメンテーション分析：

世界の着床前遺伝子診断市場は、タイプ、技術、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプ別に6つに区分される：染色体異常、異数性、X連鎖性疾患、単一遺伝子障害、HLAタイピング、性別選択、その他。市場セグメンテーションでは、異数体異常が支配的な地位を占めています。異数性は、発達上の課題、流産、先天異常などを引き起こす可能性があります。そのため、体外受精を希望する家族にとって、その識別は不可欠です。

市場は技術によって3つのセグメントに分類される：次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、蛍光in-situハイブリダイゼーション（FISH）、およびその他の方法です。ポリメラーゼ連鎖反応（PCR）は市場で主導的地位を占めています。この強固な分子生物学的手法は、特定のDNA配列を増幅するために採用され、着床前遺伝子診断（PGD）などの遺伝子検査において不可欠な機器となっています。

市場はエンドユーザーによって、不妊治療センター、病院、診断センター、研究センター、学術研究所、その他の4つに区分されます。市場をリードするのは病院部門です。病院は体外受精のような重要な臨床サービスを提供しており、PGDプロセスの初期段階として機能することが多いです。病院内に生殖医療専門部門が存在することで、遺伝子検査を希望する患者にとってPGDへのアクセスが向上します。

着床前遺伝子診断市場-地理的洞察

北米は最先端医療技術により市場拡大をリードしています。この地域は、世界的に最も洗練された医療技術と研究機関を擁していることで知られています。次世代シーケンシング（NGS）やハイスループットスクリーニング技術など、革新的な遺伝子検査法への多額の投資により、PGDの効率と精度が大幅に向上し、患者やヘルスケア専門家の間で支持されています。米国は世界最大の医療機器市場であり、世界の医療技術セクターの40％以上を占めています。アジア太平洋地域は、不妊率の増加やヘルスケア・インフラの進歩に後押しされ、かなりの成長の可能性を示しています。

着床前遺伝子診断市場-競合情勢：

着床前遺伝子診断（PGD）市場は、複数の有力参入企業、技術革新、遺伝子スクリーニングサービスに対するニーズの高まりを特徴とする競合環境を示しています。遺伝子検査に重点を置く組織はPGD市場にとって不可欠であり、胚評価に必要な技術と専門知識を提供しています。PGD市場の競争力学は、技術の進歩によって大きく形成されています。次世代シーケンシング（NGS）やマルチプレックスPCRなど、より効果的で正確な遺伝子検査手法を開発する企業が競争優位性を確保します。継続的な技術革新は、遺伝子異常の特定における感度と特異性の向上に寄与します。

目次

第1章 着床前遺伝子診断市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 着床前遺伝子診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 着床前遺伝子診断産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 着床前遺伝子診断市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 着床前遺伝子診断市場情勢

  • 着床前遺伝子診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 着床前遺伝子診断市場- タイプ別

  • 概要
    • セグメントシェア分析
    • 染色体異常
    • 異数性
    • X連鎖疾患
    • 単一遺伝子疾患
    • HLAタイピング
    • 性別の選択
    • その他

第8章 着床前遺伝子診断市場- 技術別

  • 概要
    • セグメントシェア分析
    • 次世代シーケンシング（NGS）
    • ポリメラーゼ連鎖反応（PCR）
    • 蛍光in-situハイブリダイゼーション（FISH）
    • その他

第9章 着床前遺伝子診断市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 不妊治療センター
    • 病院
    • 診断センター
    • 研究センターと学術研究室
    • その他

第10章 着床前遺伝子診断市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 着床前遺伝子診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Quest Diagnostics Incorporated
    • Natera, Inc.
    • COOPER SURGICAL, INC.
    • Genea Pty Limited.
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Bioarray SL
    • Illumina, Inc.
    • Igenomix
    • RGI
    • F. Hoffmann-La Roche Ltd
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4228

REPORT HIGHLIGHT

The Preimplantation Genetic Diagnosis Market was valued at USD 57.80 Million in 2023 and expanded at a CAGR of 7.80% from 2024 to 2032.

Pre-implantation genetic diagnosis (PGD) is a laboratory technique employed alongside in vitro fertilization (IVF) to minimize the likelihood of transmitting hereditary disorders. The primary motivations for utilizing PGD include the presence of particular single-gene disorders, such as polycystic kidney disease, cystic fibrosis, and sickle cell anemia, as well as chromosomal abnormalities in a parent. Additionally, families may opt for PGD when a relative requires a bone marrow donor, enabling them to conceive a child capable of supplying compatible stem cells.

Preimplantation Genetic Diagnosis Market- Market Dynamics

The rising Prevalence of Genetic Disorders is anticipated to drive the growth of the market

Preimplantation Genetic Diagnosis (PGD) offers a significant solution by enabling the selection of embryos free from certain genetic abnormalities. This emphasis on promoting healthy births encourages an increasing number of couples to incorporate PGD into their reproductive strategies. According to the World Health Organization, genetic disorders and congenital anomalies are present in approximately 2%-5% of all live births, contribute to nearly 30% of pediatric hospital admissions, and are responsible for about 50% of childhood fatalities in developed nations.

Additionally, the expansion of fertility clinics and ongoing advancements in genetic testing technologies may present growth opportunities for the market. However, the high costs associated with PGD services could hinder market expansion.

Preimplantation Genetic Diagnosis Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.80% over the forecast period (2024-2032)

Based on Type segmentation, Aneuploidy was predicted to show maximum market share in the year 2023

Based on Technology segmentation, Polymerase Chain Reaction (PCR) was the leading type in 2023

Based on End-User segmentation, the hospital was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Preimplantation Genetic Diagnosis Market- Segmentation Analysis:

The Global Preimplantation Genetic Diagnosis Market is segmented based on Type, Technology, End-User, and Region.

The market is segmented into six categories according to Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, and others. The segment about Aneuploidy holds a dominant position within the market. Aneuploidy may result in developmental challenges, miscarriages, or congenital anomalies. Consequently, its identification is essential for families pursuing in vitro fertilization.

The market is classified into three segments according to technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), and additional methods. Polymerase Chain Reaction (PCR) holds a leading position in the market. This robust molecular biology technique is employed to amplify particular DNA sequences, rendering it an essential instrument in genetic testing, such as Preimplantation Genetic Diagnosis (PGD).

The market is segmented into four categories according to End-User: Fertility Centers, Hospitals, Diagnostic Centers, Research Centers, Academic Laboratories, and Others. The hospital sector leads the market. Hospitals offer critical clinical services, such as IVF procedures, which frequently serve as the initial phase in the PGD process. The existence of dedicated reproductive health departments within hospitals improves accessibility to PGD for patients pursuing genetic testing.

Preimplantation Genetic Diagnosis Market- Geographical Insights

North America leads the market expansion, attributed to its cutting-edge medical technologies. This region is recognized for hosting some of the most sophisticated medical technologies and research institutions globally. The substantial investment in innovative genetic testing methods, including next-generation sequencing (NGS) and high-throughput screening techniques, significantly improves the efficiency and precision of PGD, rendering it a favored option among patients and healthcare professionals. The United States is the largest medical device market worldwide, accounting for over 40% of the global medtech sector. Europe closely follows in market presence, while the Asia-Pacific region exhibits considerable growth potential, fueled by increasing infertility rates and advancements in healthcare infrastructure.

Preimplantation Genetic Diagnosis Market- Competitive Landscape:

The Preimplantation Genetic Diagnosis (PGD) Market presents a competitive environment marked by several prominent participants, technological innovations, and an increasing need for genetic screening services. Organizations focused on genetic testing are essential to the PGD market, offering the requisite technologies and expertise for embryo evaluation. The competitive dynamics within the PGD market are significantly shaped by advancements in technology. Firms that create more effective and precise genetic testing methodologies, including next-generation sequencing (NGS) and multiplex PCR, secure a competitive advantage. Ongoing innovation contributes to enhanced sensitivity and specificity in identifying genetic anomalies.

Recent Developments:

AUSTIN, Texas Natera, Inc., a prominent global entity in the field of cell-free DNA and genetic testing, has announced that it will unveil new findings regarding its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, at the upcoming 2024 European Society for Medical Oncology (ESMO) Congress, scheduled for September 13-16 in Barcelona, Spain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quest Diagnostics Incorporated
  • Natera, Inc.
  • COOPER SURGICAL, INC.
  • Genea Pty Limited.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific Inc.
  • Bioarray S.L.
  • Illumina, Inc.
  • Igenomix
  • RGI
  • F. Hoffmann-La Roche Ltd
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescent In-Situ Hybridization (FISH)
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Fertility Centers
  • Hospitals
  • Diagnostic Centers
  • Research Centers and Academic Labs
  • Others

GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preimplantation Genetic Diagnosis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preimplantation Genetic Diagnosis Market Snippet by Type
    • 2.1.2. Preimplantation Genetic Diagnosis Market Snippet by Technology
    • 2.1.3. Preimplantation Genetic Diagnosis Market Snippet by End-User
    • 2.1.4. Preimplantation Genetic Diagnosis Market Snippet by Country
    • 2.1.5. Preimplantation Genetic Diagnosis Market Snippet by Region
  • 2.2. Competitive Insights

3. Preimplantation Genetic Diagnosis Key Market Trends

  • 3.1. Preimplantation Genetic Diagnosis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preimplantation Genetic Diagnosis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preimplantation Genetic Diagnosis Market Opportunities
  • 3.4. Preimplantation Genetic Diagnosis Market Future Trends

4. Preimplantation Genetic Diagnosis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preimplantation Genetic Diagnosis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Preimplantation Genetic Diagnosis Market Landscape

  • 6.1. Preimplantation Genetic Diagnosis Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preimplantation Genetic Diagnosis Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Chromosomal Abnormalities
    • 7.1.3. Aneuploidy
    • 7.1.4. X-linked diseases
    • 7.1.5. Single Gene Disorders
    • 7.1.6. HLA Typing
    • 7.1.7. Gender selection
    • 7.1.8. Others

8. Preimplantation Genetic Diagnosis Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Next Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Fluorescent In-Situ Hybridization (FISH)
    • 8.1.5. Others

9. Preimplantation Genetic Diagnosis Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Fertility Centers
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Research Centers and Academic Labs
    • 9.1.6. Others

10. Preimplantation Genetic Diagnosis Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Preimplantation Genetic Diagnosis Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Preimplantation Genetic Diagnosis Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Preimplantation Genetic Diagnosis Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Preimplantation Genetic Diagnosis Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Preimplantation Genetic Diagnosis Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Preimplantation Genetic Diagnosis Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Quest Diagnostics Incorporated
    • 11.2.2. Natera, Inc.
    • 11.2.3. COOPER SURGICAL, INC.
    • 11.2.4. Genea Pty Limited.
    • 11.2.5. Invitae Corporation
    • 11.2.6. Laboratory Corporation of America Holdings
    • 11.2.7. Thermo Fisher Scientific Inc.
    • 11.2.8. Bioarray S.L.
    • 11.2.9. Illumina, Inc.
    • 11.2.10. Igenomix
    • 11.2.11. RGI
    • 11.2.12. F. Hoffmann-La Roche Ltd
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us